FDA Inspection
Tris Pharma Inc.Tris Pharma Inc. – FDA Inspection, Nov 21, 2025
Record Details
This FDA Inspection record concerns Tris Pharma Inc., with an inspection on November 21, 2025, issued by the New Jersey District Office, covering human drugs.
View Company Profile
ID · b0a66ca1-e50e-48d8-8bb1-9e1b4802753b
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1289086
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
1- 21 CFR 211.192Investigations of discrepancies, failures
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Tris Pharma Inc.
13| Date | Classification | Office | Project area |
|---|---|---|---|
| March 8, 2024 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| June 8, 2021 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| January 23, 2019 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 16, 2018 | VAI | Center for Drug Evaluation and Research | Postmarket Surv. and Epidemiology |
| March 20, 2017 | OAI | Center for Drug Evaluation and Research | New Drug Evaluation |
Other documents for Tris Pharma Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.